ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 215 filers reported holding ARRAY BIOPHARMA INC in Q3 2018. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $10,255,000 | +576.9% | 221,330 | +256.1% | 0.00% | +300.0% |
| Q1 2019 | $1,515,000 | +225.1% | 62,157 | +90.1% | 0.00% | – |
| Q4 2018 | $466,000 | +166.3% | 32,704 | +183.6% | 0.00% | – |
| Q3 2018 | $175,000 | +2.3% | 11,530 | +13.7% | 0.00% | – |
| Q2 2018 | $171,000 | -19.0% | 10,138 | -21.3% | 0.00% | – |
| Q1 2018 | $211,000 | +379.5% | 12,874 | +266.7% | 0.00% | – |
| Q4 2017 | $44,000 | -80.8% | 3,511 | -81.1% | 0.00% | – |
| Q3 2017 | $229,000 | +2762.5% | 18,620 | +1889.3% | 0.00% | – |
| Q2 2017 | $8,000 | -87.7% | 936 | -87.1% | 0.00% | – |
| Q1 2017 | $65,000 | -83.4% | 7,264 | -83.7% | 0.00% | – |
| Q4 2016 | $392,000 | +1407.7% | 44,579 | +1070.1% | 0.00% | – |
| Q3 2016 | $26,000 | -35.0% | 3,810 | -66.3% | 0.00% | – |
| Q2 2016 | $40,000 | -11.1% | 11,310 | -27.5% | 0.00% | – |
| Q1 2016 | $45,000 | -70.2% | 15,590 | -56.1% | 0.00% | – |
| Q4 2015 | $151,000 | -30.7% | 35,535 | -25.8% | 0.00% | – |
| Q3 2015 | $218,000 | +194.6% | 47,875 | +363.9% | 0.00% | – |
| Q2 2015 | $74,000 | 0.0% | 10,321 | -36.4% | 0.00% | – |
| Q2 2014 | $74,000 | +362.5% | 16,225 | +377.2% | 0.00% | – |
| Q1 2014 | $16,000 | -87.4% | 3,400 | -86.6% | 0.00% | – |
| Q4 2013 | $127,000 | -21.1% | 25,336 | -2.4% | 0.00% | – |
| Q3 2013 | $161,000 | +66.0% | 25,960 | +22.1% | 0.00% | – |
| Q2 2013 | $97,000 | – | 21,254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 16,618,776 | $146,079,000 | 12.59% |
| BVF INC/IL | 4,986,186 | $43,829,000 | 8.81% |
| First Light Asset Management, LLC | 1,000,361 | $8,793,000 | 3.86% |
| Crosspoint Capital Strategies, LLC | 463,005 | $4,070,000 | 3.62% |
| Consonance Capital Management LP | 2,723,471 | $23,912,000 | 2.63% |
| KOPP INVESTMENT ADVISORS LLC | 219,926 | $1,933,000 | 2.04% |
| SPHERA FUNDS MANAGEMENT LTD. | 900,000 | $7,911,000 | 2.00% |
| Orbimed Advisors | 16,088,800 | $141,421,000 | 1.80% |
| Cormorant Asset Management, LP | 1,150,000 | $10,109,000 | 1.36% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 2,073,680 | $18,227,000 | 1.26% |